Parabilis Medicines Inc (PBLS)

Finanzdaten der Parabilis Medicines Inc-Aktie (PBLS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30
Periodenlänge	3 Monate
Revenues	0.15
	51.03
Research and Development	39.38
Depreciation and Amortization	0.60
Operating Income/Loss	-50.89
Nonoperating Income/Loss	-1.58
	-52.46
Attributable To Parent	-52.46
Available To Common Stockholders, Basic	-66.96
Basic Average Shares	28.91
Diluted Average Shares	28.91
Basic Earnings Per Share	-2.32
Diluted Earnings Per Share	-2.32